Registro:

Referencias:

• Heinrichs, S.C., Koob, G.F., Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation (2004) J. Pharmacol. Exp. Ther., 311, pp. 427-440
• Steckler, T., Holsboer, F., Corticotropin-releasing hormone receptor subtypes and emotion (1999) Biol. Psychiatry, 46, pp. 1480-1508
• Herman, J.P., Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness (2003) Front. Neuroendocrinol., 24, pp. 151-180
• Grammatopoulos, D.K., Chrousos, G.P., Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists (2002) Trends Endocrinol. Metab., 13, pp. 436-444
• Dautzenberg, F.M., Hauger, R.L., The CRF peptide family and their receptors: yet more partners discovered (2002) Trends Pharmacol. Sci., 23, pp. 71-77
• Grigoriadis, D.E., The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders (2005) Expert Opin. Ther. Targets, 9, pp. 651-684
• Merchenthaler, I., Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain (1982) Am. J. Anat., 165, pp. 385-396
• Swanson, L.W., Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study (1983) Neuroendocrinology, 36, pp. 165-186
• Bittencourt, J.C., Sawchenko, P.E., Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system (2000) J. Neurosci., 20, pp. 1142-1156
• Chen, Y., Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF1)-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus (2000) J. Comp. Neurol., 420, pp. 305-323
• Chalmers, D.T., Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression (1995) J. Neurosci., 15, pp. 6340-6350
• Reul, J.M., Holsboer, F., Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression (2002) Curr. Opin. Pharmacol., 2, pp. 23-33
• Nemeroff, C.B., Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims (1988) Arch. Gen. Psychiatry, 45, pp. 577-579
• Nemeroff, C.B., Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients (1984) Science, 226, pp. 1342-1344
• Holsboer, F., Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression (1984) N. Engl. J. Med., 311, p. 1127
• Raadsheer, F.C., Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression (1995) Am. J. Psychiatry, 152, pp. 1372-1376
• Zobel, A.W., Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated (2000) J. Psychiatr. Res., 34, pp. 171-181
• Holsboer, F., The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety (1999) J. Psychiatr. Res., 33, pp. 181-214
• Muller, M.B., Holsboer, F., Mice with mutations in the HPA-system as models for symptoms of depression (2006) Biol. Psychiatry, 59, pp. 1104-1115
• Stenzel-Poore, M.P., Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior (1994) J. Neurosci., 14, pp. 2579-2584
• Dirks, A., Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations (2002) Eur. J. Neurosci., 16, pp. 1751-1760
• Smith, G.W., Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development (1998) Neuron, 20, pp. 1093-1102
• Timpl, P., Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 (1998) Nat. Genet., 19, pp. 162-166
• Muller, M.B., Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress (2003) Nat. Neurosci., 6, pp. 1100-1107
• Philips, A., Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells (1997) Mol. Cell. Biol., 17, pp. 5946-5951
• Zhao, J., Karalis, K.P., Regulation of nuclear factor-κB by corticotropin-releasing hormone in mouse thymocytes (2002) Mol. Endocrinol., 16, pp. 2561-2570
• Karalis, K.P., NF-κB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene (2004) J. Biol. Chem., 279, pp. 10837-10840
• Lezoualc'h, F., Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β precursor protein and with the suppression of nuclear factor-κB (2000) Mol. Endocrinol., 14, pp. 147-159
• Vila, G., Sonic hedgehog regulates CRH signal transduction in the adult pituitary (2005) FASEB J., 19, pp. 281-283
• Cao, J., Corticotropin-releasing hormone (CRH) induces vascular endothelial growth factor (VEGF) release from human mast cells via the cAMP/protein kinase A/p38 MAPK pathway (2005) Mol Pharmacol
• Wang, W., Corticotropin-releasing hormone induces proliferation and TNF-α release in cultured rat microglia via MAP kinase signalling pathways (2003) J. Neurochem., 84, pp. 189-195
• Kovalovsky, D., Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways (2002) Mol. Endocrinol., 16, pp. 1638-1651
• Grammatopoulos, D.K., Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1α and R2β CRH receptor subtypes and stimulation of Gq-proteins (2000) Mol. Endocrinol., 14, pp. 2076-2091
• Brar, B.K., Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides (2004) Endocrinology, 145, pp. 1718-1729
• Rossant, C.J., Corticotropin-releasing factor type 1 and type 2α receptors regulate phosphorylation of calcium/cyclic adenosine 3′,5′-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase (1999) Endocrinology, 140, pp. 1525-1536
• Bayatti, N., Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons (2003) Endocrinology, 144, pp. 4051-4060
• Cibelli, G., Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways (2001) Eur. J. Neurosci., 13, pp. 1339-1348
• Swinny, J.D., Corticotropin-releasing factor and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro (2004) Eur. J. Neurosci., 19, pp. 1749-1758
• Elliott-Hunt, C.R., Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus (2002) J. Neurochem., 80, pp. 416-425
• Radulovic, M., Corticotropin-releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases (2003) J. Neurochem., 84, pp. 1074-1085
• Dermitzaki, E., Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase (2002) J. Biol. Chem., 277, pp. 12280-12287
• Hoare, S.R., Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands (2003) Peptides, 24, pp. 1881-1897
• Blank, T., Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning (2003) J. Neurosci., 23, pp. 700-707
• Liu, J.P., A comparative study of the role of adenylate cyclase in the release of adrenocorticotropin from the ovine and rat anterior pituitary (1994) Mol. Cell. Endocrinol., 101, pp. 173-181
• Pelton, G.H., Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex (1997) Brain Res., 778, pp. 381-387
• Serradeil-Le Gal, C., An overview of SSR149415, a selective nonpeptide vasopressin V1b receptor antagonist for the treatment of stress-related disorders (2005) CNS Drug Rev., 11, pp. 53-68
• Kim, E., Sheng, M., PDZ domain proteins of synapses (2004) Nat. Rev. Neurosci., 5, pp. 771-781
• Kim, J.H., SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family (1998) Neuron, 20, pp. 683-691
• Colledge, M., Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex (2000) Neuron, 27, pp. 107-119
• Grewal, S.S., Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase (2000) J. Biol. Chem., 275, pp. 3722-3728
• Thomas, G.M., Huganir, R.L., MAPK cascade signalling and synaptic plasticity (2004) Nat. Rev. Neurosci., 5, pp. 173-183
• Menard, C., An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis (2002) Neuron, 36, pp. 597-610
• Traverse, S., EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor (1994) Curr. Biol., 4, pp. 694-701
• English, J.D., Sweatt, J.D., A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation (1997) J. Biol. Chem., 272, pp. 19103-19106
• Selcher, J.C., A necessity for MAP kinase activation in mammalian spatial learning (1999) Learn. Mem., 6, pp. 478-490
• Schafe, G.E., Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning (2000) J. Neurosci., 20, pp. 8177-8187
• Meller, E., Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases (2003) Brain Res., 979, pp. 57-64
• Hao, Y., Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis (2004) J. Neurosci., 24, pp. 6590-6599
• Einat, H., The role of the extracellular signal-regulated kinase signaling pathway in mood modulation (2003) J. Neurosci., 23, pp. 7311-7316
• Refojo, D., Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 6183-6188
• Cohen, P., Protein kinases-the major drug targets of the twenty-first century? (2002) Nat. Rev. Drug Discov., 1, pp. 309-315
• Bain, J., The specificities of protein kinase inhibitors: an update (2003) Biochem. J., 371, pp. 199-204
• Duan, W., Wong, W.S., Targeting mitogen-activated protein kinases for asthma (2006) Curr. Drug Targets, 7, pp. 691-698
• de Kloet, E.R., Stress and the brain: from adaptation to disease (2005) Nat. Rev. Neurosci., 6, pp. 463-475

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------